Stay updated on SB17 vs Stelara in Plaque Psoriasis Clinical Trial

Sign up to get notified when there's something new on the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record describes a completed Phase 3 comparison of the proposed ustekinumab biosimilar SB17 and Stelara for moderate-to-severe plaque psoriasis, including study design, eligibility criteria, locations, outcomes, and posted results. It also provides the study protocol and statistical analysis plan.
    Difference
    55%
    Check dated 2026-11-11T01:22:43.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:38:06.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH announcement about website updates and the use of “Super Intelligence” terminology appears above the 403 error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:28:07.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:07:28.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, replacing the study record with an access-denied message and removing visible study details.
    Difference
    17%
    Check dated 2026-09-23T00:36:31.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates an updated version of the page used for tracking changes, with likely backend or layout updates rather than changes to study information.
    Difference
    0.0%
    Check dated 2026-09-15T23:52:37.000Z thumbnail image

Stay in the know with updates to SB17 vs Stelara in Plaque Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page.